Cargando…

Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling

BACKGROUND: Our work was motivated by the need to, given serum availability and/or financial resources, decide on which samples to test in a serum bank for different pathogens. Simulation-based sample size calculations were performed to determine the age-based sampling structures and optimal allocat...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaizot, Stéphanie, Herzog, Sereina A., Abrams, Steven, Theeten, Heidi, Litzroth, Amber, Hens, Niel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407263/
https://www.ncbi.nlm.nih.gov/pubmed/30845904
http://dx.doi.org/10.1186/s12874-019-0692-1
_version_ 1783401512624455680
author Blaizot, Stéphanie
Herzog, Sereina A.
Abrams, Steven
Theeten, Heidi
Litzroth, Amber
Hens, Niel
author_facet Blaizot, Stéphanie
Herzog, Sereina A.
Abrams, Steven
Theeten, Heidi
Litzroth, Amber
Hens, Niel
author_sort Blaizot, Stéphanie
collection PubMed
description BACKGROUND: Our work was motivated by the need to, given serum availability and/or financial resources, decide on which samples to test in a serum bank for different pathogens. Simulation-based sample size calculations were performed to determine the age-based sampling structures and optimal allocation of a given number of samples for testing across various age groups best suited to estimate key epidemiological parameters (e.g., seroprevalence or force of infection) with acceptable precision levels in a cross-sectional seroprevalence survey. METHODS: Statistical and mathematical models and three age-based sampling structures (survey-based structure, population-based structure, uniform structure) were used. Our calculations are based on Belgian serological survey data collected in 2001–2003 where testing was done, amongst others, for the presence of Immunoglobulin G antibodies against measles, mumps, and rubella, for which a national mass immunisation programme was introduced in 1985 in Belgium, and against varicella-zoster virus and parvovirus B19 for which the endemic equilibrium assumption is tenable in Belgium. RESULTS: The optimal age-based sampling structure to use in the sampling of a serological survey as well as the optimal allocation distribution varied depending on the epidemiological parameter of interest for a given infection and between infections. CONCLUSIONS: When estimating epidemiological parameters with acceptable levels of precision within the context of a single cross-sectional serological survey, attention should be given to the age-based sampling structure. Simulation-based sample size calculations in combination with mathematical modelling can be utilised for choosing the optimal allocation of a given number of samples over various age groups. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-019-0692-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6407263
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64072632019-03-21 Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling Blaizot, Stéphanie Herzog, Sereina A. Abrams, Steven Theeten, Heidi Litzroth, Amber Hens, Niel BMC Med Res Methodol Research Article BACKGROUND: Our work was motivated by the need to, given serum availability and/or financial resources, decide on which samples to test in a serum bank for different pathogens. Simulation-based sample size calculations were performed to determine the age-based sampling structures and optimal allocation of a given number of samples for testing across various age groups best suited to estimate key epidemiological parameters (e.g., seroprevalence or force of infection) with acceptable precision levels in a cross-sectional seroprevalence survey. METHODS: Statistical and mathematical models and three age-based sampling structures (survey-based structure, population-based structure, uniform structure) were used. Our calculations are based on Belgian serological survey data collected in 2001–2003 where testing was done, amongst others, for the presence of Immunoglobulin G antibodies against measles, mumps, and rubella, for which a national mass immunisation programme was introduced in 1985 in Belgium, and against varicella-zoster virus and parvovirus B19 for which the endemic equilibrium assumption is tenable in Belgium. RESULTS: The optimal age-based sampling structure to use in the sampling of a serological survey as well as the optimal allocation distribution varied depending on the epidemiological parameter of interest for a given infection and between infections. CONCLUSIONS: When estimating epidemiological parameters with acceptable levels of precision within the context of a single cross-sectional serological survey, attention should be given to the age-based sampling structure. Simulation-based sample size calculations in combination with mathematical modelling can be utilised for choosing the optimal allocation of a given number of samples over various age groups. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12874-019-0692-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-07 /pmc/articles/PMC6407263/ /pubmed/30845904 http://dx.doi.org/10.1186/s12874-019-0692-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Blaizot, Stéphanie
Herzog, Sereina A.
Abrams, Steven
Theeten, Heidi
Litzroth, Amber
Hens, Niel
Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
title Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
title_full Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
title_fullStr Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
title_full_unstemmed Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
title_short Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
title_sort sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407263/
https://www.ncbi.nlm.nih.gov/pubmed/30845904
http://dx.doi.org/10.1186/s12874-019-0692-1
work_keys_str_mv AT blaizotstephanie samplesizecalculationforestimatingkeyepidemiologicalparametersusingserologicaldataandmathematicalmodelling
AT herzogsereinaa samplesizecalculationforestimatingkeyepidemiologicalparametersusingserologicaldataandmathematicalmodelling
AT abramssteven samplesizecalculationforestimatingkeyepidemiologicalparametersusingserologicaldataandmathematicalmodelling
AT theetenheidi samplesizecalculationforestimatingkeyepidemiologicalparametersusingserologicaldataandmathematicalmodelling
AT litzrothamber samplesizecalculationforestimatingkeyepidemiologicalparametersusingserologicaldataandmathematicalmodelling
AT hensniel samplesizecalculationforestimatingkeyepidemiologicalparametersusingserologicaldataandmathematicalmodelling